Filing Flows › Comparisons › RGBP vs CLNN
Regen BioPharma vs Clene: RGBP and CLNN compared
Regen BioPharma is the larger company: $59K of revenue in its latest quarter (Q3 FY26) against $56K for Clene (Q3 2026). Clene is growing faster (+273% against 0% a year earlier).
Where the money goes: RGBP and CLNN
Regen BioPharma (RGBP) · Q3 FY26
Regen BioPharma, Q3 FY26: revenue $59K (0% year over year), operating margin 41.5%, net loss $638K, operating cash flow −$24K. The chart follows the revenue to costs, profit and cash.
Clene (CLNN) · Q3 2026
Clene, Q3 2026: revenue $56K (+273% year over year), net earnings $3.9M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.
| Regen BioPharma (RGBP) | Clene (CLNN) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q3 2026 |
| Revenue | $59K | $56K |
| Revenue growth, Y/Y | 0% | +273% |
| Operating margin | 41.5% | n/m |
| Net earnings | −$638K | $3.9M |
| Operating cash flow | −$24K | −$4.6M |
Where the revenue comes from
Clene
- Product: $43K (77%)
- Royalty: $13K (23%)
Questions
Which is bigger, Regen BioPharma or Clene?
Regen BioPharma is the larger company: $59K of revenue in its latest quarter (Q3 FY26) against $56K for Clene (Q3 2026).
Is Regen BioPharma or Clene growing faster?
Clene is growing faster (+273% against 0% a year earlier).
More: Regen BioPharma earnings · how Regen BioPharma makes money · Clene earnings · how Clene makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 17, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.